| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sr. MD & CAO
1 company
Robert Bryan Eisman last filed a Form 4 in March 2025, as Sr. MD & CAO at OSG. Robert Bryan Eisman's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 70,108 shares of OSG. Net of sales, the OSG filings show accumulation of 2,000 shares.
Robert Bryan Eisman has 36 Form 4 filings on record from December 2015 to March 2025, all as Sr. MD & CAO at Octave Specialty Group (OSG), 2015–2025.
The 90 reported transactions were 35 tax withholdings, 33 option exercises, 16 option or other derivative awards and 3 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $30K and no sales.
The only open-market purchase was 2,000 shares of OSG at an average $15.17 on May 30, 2019, about $30K.
Shares as reported in the last Form 4 for each company; the most recent is from March 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 30, 2019 | OSG Octave Specialty Group Inc | Sr. MD & CAO | Buy | 2,000 | $15.17 | $30,349.95 | +9.4% |